CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.

24-2002

📡 5G SEP • ETSI Declared

Overview

Case Number 24-2002
Filing Date 2024-06-25
Status Litigation filed
Court Court of Appeals for the Federal Circuit (cafc)
Nature of Suit 830 Patent Infringement (Fed. Qst.)
Cause of Action 35:271 Patent Infringement

Parties

Defendant

AMGEN INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

FORMYCON AG NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

SAMSUNG BIOEPIS CO., LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

CELLTRION, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

AMGEN USA, INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff - Appellee

REGENERON PHARMACEUTICALS, INC. Operating Company

Represented By

12 Attorneys Listed

Elizabeth Weiswasser

Paul, Weiss, Rifkind, Wharton & Garrison LLP

1285 Avenue of the Americas, New York, NY 10019-6064

Andrew V. Trask

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Priyata Patel, AT

Paul, Weiss, Rifkind, Wharton & Garrison LLP

2001 K Street, NW, Washington, DC 20006

Adam Pan, Attorney

Williams & Connolly LLP

680 Maine Avenue, SW, Washington, DC 20024

Shaun Patrick Mahaffy

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Rhochelle Krawetz, -

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Kathryn Schleckser Kayali

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Jacob Hartman, -

Kellogg, Hansen, Todd, Figel & Frederick, PLLC

Suite 400, 1615 M Street, NW

Christian Gladden-Sorensen, -

Williams & Connolly LLP

680 Maine Avenue, SW, Washington, DC 20024

Thomas S. Fletcher

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Arthur John Argall, III, -

Williams & Connolly LLP

680 Maine Avenue SW, 20024

David I. Berl, Esq.

Williams & Connolly LLP

680 Maine Avenue SW, 20024

Defendant - Appellant

BIOCON BIOLOGICS INC. Operating Company

Represented By

7 Attorneys Listed

Heinz Johann Salmen, Attorney

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

Paul J. Molino, Attorney

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Neil McLaughlin, Litigation Counsel

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Deanne M. Mazzochi, -

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Lauren Marie Lesko

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

Eric R. Hunt

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

William A. Rakoczy

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

MYLAN PHARMACEUTICALS INC. Operating Company

Represented By

7 Attorneys Listed

Heinz Johann Salmen, Attorney

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

Paul J. Molino, Attorney

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Neil McLaughlin, Litigation Counsel

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Deanne M. Mazzochi, -

Rakoczy Molino Mazzochi Siwik LLP

6 W Hubbard Street, Chicago, IL 60654

Lauren Marie Lesko

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

Eric R. Hunt

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

William A. Rakoczy

Rakoczy Molino Mazzochi Siwik LLP

Suite 500, 6 W Hubbard Street

Court & Judges

Court

Court of Appeals for the Federal Circuit (cafc)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP • ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 5G NR Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Samsung

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

âś“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
âś“ Right to demand global FRAND portfolio determination.
âś“ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

(58 total)

Appeal docketed. Received: 06/21/2024. [1013376]Entry of Appearance is due on 07/09/2024. Certificate of Interest is due on 07/09/2024. Docketing Statement is due on 07/09/2024. Appellants' brief is due on 08/26/2024. [JSP] [Entered: 06/25/2024 02:59 PM]

Entry #1 • 2024-06-25
1

Certificate of Interest for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014126] [24-2002] [Deanne Mazzochi] [Entered: 06/27/2024 10:05 PM]

Entry #2 • 2024-06-27
1

Docketing Statement for the Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014128] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:16 PM]

Entry #3 • 2024-06-27
1

Notice of Related Case Information for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014129] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:19 PM]

Entry #4 • 2024-06-27
1

Entry of Appearance for William A. Rakoczy; Heinz J. Salmen; Paul J. Molino; Deanne M. Mazzochi; Eric R. Hunt; Lauren M. Lesko; Neil B. McLaughlin as counsel for Appellants Biocon Biologics Inc. and Mylan Pharmaceuticals Inc.. Service: 06/27/2024 by email. [1014132] [24-2002] [William Rakoczy] [Entered: 06/27/2024 10:28 PM]

Entry #5 • 2024-06-27
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc